Targeted Temperature management (Therapeutic Hypothermia) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Targeted Temperature management (Therapeutic Hypothermia) Market is expected to grow at a CAGR of 6% during the forecast period 2022-2028.

Therapeutic hypothermia, also known as targeted temperature management or protective hypothermia, is the reduction of body temperature from 32°C to 34°C for rapid recovery. Therapeutic hypothermia is important in the treatment of cardiovascular diseases such as cardiac arrest and myocardial infarction. Improves nervous system function after cardiac arrest resuscitation. Body temperature management involves heating or cooling to maintain a normal core body temperature. Basic procedures include intentional hypothermia (low body temperature), rewarming from hypothermia, or maintaining a desired normal core body temperature. By implementing the patient body temperature management system, we are contributing to the reduction of treatment costs by reducing surgical site infections and shortening the hospital stay. TTM is used in various clinical areas such as neurology, cardiovascular diseases such as cardiac arrest and myocardial infarction, and sepsis. It is considered an established protective adjuvant in neurosurgery, cardiovascular surgery, and endovascular aneurysm repair.

Market Segments

By Technique Type

• Non-invasive
• Invasive

By Device Type

• Patient Warming Systems
• Patient Cooling Systems

By Application

• Neurology
• Cardiology
• Neonatal care
• Orthopedics

Key Players

The Global Targeted Temperature management (Therapeutic Hypothermia) Market Company Profiles are Smiths Medical, Inc, Financial Overview, Medtronic Plc, Stryker Corporation, 3M Health Care, Qool Therapeutics, Seiratherm GmbH, ZOLL Medical Corporation, Gentherm (Cincinnati Sub-Zero Products), Becton, Dickinson and Company, Drägerwerk AG & Co. KGaA, EMCOOLS Medical Cooling Systems GmbH, Attune Medical, BrainCool AB, Belmont Medical Technologies.

Scope of the Report

The research study analyzes the global Targeted Temperature management (Therapeutic Hypothermia) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Targeted Temperature management (Therapeutic Hypothermia) Market Report

1. What was the Targeted Temperature management (Therapeutic Hypothermia) Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Targeted Temperature management (Therapeutic Hypothermia) Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Targeted Temperature management (Therapeutic Hypothermia) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.